Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Group-Based Walking Study Using WeChat to Enhance Physical Activity Among Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03803085
Recruitment Status : Completed
First Posted : January 14, 2019
Results First Posted : November 9, 2020
Last Update Posted : November 9, 2020
Sponsor:
Information provided by (Responsible Party):
Brandeis University

Brief Summary:
The aim for the study is to use the function WeRun in the application WeChat to encourage physical activity and social engagement among community dwelling older adults and their family members and friends. The specific aims are to test the effectiveness of a social contact and comparison intervention for increasing regular daily physical activity among community dwelling older adults, and to examine the potential effectiveness of WeChat in cultivating social engagement and well-being among community dwelling older adults.

Condition or disease Intervention/treatment Phase
Inactivity Sedentary Behavior Behavioral: Control condition Behavioral: Treatment condition Not Applicable

Detailed Description:

The aim for the study is to use the function WeRun in the application WeChat to encourage physical activity and social engagement among community dwelling older adults. The investigators asked participants in the social engagement group to use the WeRun function in WeChat to track their daily walking steps and to compare their performance with their group members for 4 weeks. To encourage social engagement among their group members, the daily walking steps were calculated and the participant who has the highest step count in the group will be indicated each day.Those in the control group will only use the WeRun function in WeChat to track their own walking steps.

The investigators expected that the participants in the social contact group will walk more often and report more social activities than those in the control group, who will not compete with their peers in daily walking. To test these predictions, daily walking steps and the total walking steps per week were obtained and compared across groups. The nature and the extent of change was analyzed over the four weeks. Exercise self-efficacy was measured using a measure based on Bandura's model. Social engagement was measured using the short Lubben Social Network Scale, a self report measure of social engagement on a 12-item scale, and physical activity was measured using International Physical Activity Questionnaire (IPAQ), a self-report measure of physical activity on a 12-item scale.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A total of 60 adults were recruited and randomly assigned to either the control condition (n=30) or the treatment condition (n=30). The 60 participants completed the study in one of three subgroups, with 20 participants randomly assigned to two groups (10 in the treatment group and 10 in the control group). Both conditions will use the WeChat App for use on a smartphone. The control group used the WeRun program to count their own steps. The treatment condition used the WeRun to engage in social contact and compare their steps with others in the group.
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: A Group-Based Walking Study Using WeChat to Enhance Physical Activity Among Older Adults: The Role of Social Engagement
Actual Study Start Date : October 30, 2018
Actual Primary Completion Date : June 1, 2019
Actual Study Completion Date : July 2, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Control Condition
Participants only saw their own daily walking steps using the WeRun function in WeChat. They did not use WeChat to see other group members' daily steps and did not engage in social contact with their group members.
Behavioral: Control condition
Participants in the control group only saw their own daily walking steps using the WeChat. They did not use WeChat to see other group members' daily steps and did not contact other group members. The participants were asked to use the app every day. A message (through WeChat) was sent to remind them to use the application if they had not done so within three days.

Experimental: Treatment condition
Participants saw their own and other group member's daily walking steps using the WeRun function in WeChat and they were able to contact the other members of their group using We Chat.
Behavioral: Treatment condition
Participants in the experimental condition used WeChat for 4 weeks to see their own and other's walking steps and also were able to contact other group members. The participants were asked to use the application every day. A message (through the group chat) was sent to remind them to use the application if they have not done so within three days.




Primary Outcome Measures :
  1. Number of Steps Walked [ Time Frame: [Time Frame: Baseline (pretest) Week, Week 4 (posttest) and Week 8 (one month follow up)] ]
    Weekly average number of steps recorded with WeRun on the phone [ (averaged across 7 days at Baseline week and averaged across 7 days at Week 4 (Posttest) and averaged across 7 days at Week 8 (one month follow up)].


Secondary Outcome Measures :
  1. Social Engagement [ Time Frame: Pretest given 1 week before the intervention and then at the posttest after the 4 week study and one month follow up ]
    Short Lubben Social Network Scale-Revised, a self-report measure of social engagement on a 12-item scale. The total score is calculated by the sum of all the items. The total score ranges between 0 and 60, with a higher score indicating more social engagement.

  2. Exercise Self Efficacy [ Time Frame: Pretest given 1 week before the intervention and then at the posttest after the 4 week study and one month follow up ]
    This scale is a self-report of exercise self-efficacy. Total score is calculated by summing the responses to each question. This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Participants who are 60 or older who have a cellphone, with either android or iPhone system with data plan.
  • They must be fit enough to walk for at least 20 minutes at a time.
  • English speaking

Exclusion Criteria:

  • Unable to walk more than 20 minutes;
  • do not have smart phone with data plan.
  • younger than 60

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03803085


Locations
Layout table for location information
United States, Massachusetts
Brandeis University
Waltham, Massachusetts, United States, 02453
Sponsors and Collaborators
Brandeis University
  Study Documents (Full-Text)

Documents provided by Brandeis University:
Informed Consent Form  [PDF] July 22, 2019

Layout table for additonal information
Responsible Party: Brandeis University
ClinicalTrials.gov Identifier: NCT03803085    
Other Study ID Numbers: 18131
First Posted: January 14, 2019    Key Record Dates
Results First Posted: November 9, 2020
Last Update Posted: November 9, 2020
Last Verified: October 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No